SHANNON CRAFT: Open Payments
NPI 1174875132 · PORTSMOUTH, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,024 in 37 payments from 14 companies in 2025. Trend: 2023 $1,518 · 2024 $1,215 · 2025 $1,024
Food & beverage: $1,024
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $264 |
| Axsome Therapeutics, Inc. | 5 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $155 |
| E.R. Squibb & Sons, L.L.C. | 1 | $83 |
| Neurocrine BioSciences, Inc. | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Gilead Sciences, Inc. | 1 | $31 |
Products named: VRAYLAR, Auvelity, CAPLYTA, COBENFY, INGREZZA, FANAPT, REXULTI, Qelbree.
Industry payments across RI — which companies pay providers there.
